Bioterrorism

Find Industry reports, Company profiles
ReportLinker and Market Statistics

>> Get this Report Now by email!

Bioterrorism
Published on July 2009

Report Summary

This report analyzes the worldwide markets for Bioterrorism in Millions of US$. The report provides separate comprehensive analytics
for the US, Europe, Asia, and Middle East. Annual forecasts are provided for each region for the period of 2001 through 2015. The
report profiles 66 companies including many key and niche players worldwide such as Acambis Plc., AVI BioPharma, Inc., Blücher
Gmbh, Evogen, Inc., Human Genome Sciences Inc., ICX Technologies, Inc., ILC Dover LP, Medarex, Inc., Northrop Grumman
Corporation, PharmAthene, Inc., Scott Health & Safety, Smiths Detection, The Baker Company, Universal Detection Technology and
Universal Detection Technology. Market data and analytics are derived from primary and secondary research. Company profiles are
mostly extracted from URL research and reported select online sources.

Table of Content

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3

II. EXECUTIVE SUMMARY

1. INTRODUCTION II-1
Current & Future Analysis II-1
Market Overview II-1

2. UNDERSTANDING BIOTERRORISM II-3
A Brief Historic Account on Bioterrorism II-3
Why Biological Agents' II-4
An Ideal Biological Weapon Candidate II-4
Bioterrorism is Easy: The Myth! II-4
Biological Agents/Diseases with Potential for Biological Warfare II-4
Properties of Biological Agents with Potential for Use as
Weapons of Mass Destruction II-5
Anthrax II-6
The Anthrax History II-6
Types of Anthrax II-7
Inhalational AnthraxII-7
Cutaneous Anthrax II-7
Gastrointestinal Anthrax II-7

Bioterrorism Page 1/8


The Anthrax Symptoms, Treatment, and Vaccination II-7
Smallpox II-8
The Smallpox History II-8
Plague II-9
The Plague History II-9
Types of Plague II-9
Bubonic Plague II-9
Pneumonic Plague II-10
Botulism II-10
Tularemia II-11
The Tularemia HistoryII-12
Viral Hemorrhagic Fevers II-12
Ebola Hemorrhagic Fever II-12
Marburg Hemorrhagic Fever II-13
Lassa Hemorrhagic Fever II-13
Q Fever II-14
Brucellosis II-15
Ricin II-16
Others II-16

3. MODES OF DELIVERY II-17
Aerosol Dissemination II-17
Water Contamination II-17
Food Contamination II-17
Insect Vectors II-17
OtherII-18

4. BIOTERRORISM DEFENSE PRODUCTS AND DETECTION EQUIPMENT II-19
DETECTION EQUIPMENT II-19
Point Detection Systems II-19
Standoff Detection Systems II-19
Passive Standoff Detection Systems II-19
Defense Products II-19
Vaccines II-19
Personal Protective EquipmentII-20

5. RECENT INDUSTRY ACTIVITYII-21
Sanofi Pasteur Acquires Acambis II-21
PharmAthene Acquires Avecia Biodefense Vaccines Business II-21
Icx Technologies Completes S3I Acquisition II-21
Johnson & Johnson to Acquire Omrix II-22
Emergent BioSolutions Enters into Joint Venture with Ninebio
Sdn Bhd II-22
Alert B&C, Frontline Robotics, and Dragon Securite Sign MoU II-22
Universal Detection and Kadinuo Sign Agreement II-23
PharmAthene Signs Marketing Pact with Medison for Israeli Market II-23
PharmAthene Forms Alliance with Panacea Biotec II-23
Innovative Biosensors and Universal Detection Plan Collaboration II-24
Acambis Wins Government Contract for ACAM2000' Smallpox Vaccine II-24
Crucell, Integrated BioTherapeutics Win NIAID Funding for



Vaccine Development II-24
Universal Detection Secures Repeat Order for Biodetection Kits II-25
Universal Detection Secures Repeat Order for Biodetection
Training Equipment II-25
Universal Detection Secures and Completes Contract II-25
Hawaii Emergency Medical Services Orders Simulation and Bio-
Detection Kits II-26
IR BioSciences Raises Financing for Drug Development II-26
AVI BioPharma Files IND for Marburg II-26
Icx Technologies Completes GHC Technologies Acquisition II-26
NanoSensors to Acquire DKL International II-27
Allen-Vanguard to Acquire Hazard Management Solutions II-27
PharmAthene Announces Reverse Merger to Acquire Healthcare
Acquisition II-27
CytoGenix Enters into CRADA with USAMRIID II-28
Advanced Life Sciences Announces Collaboration with NIAID II-28
U.S. BioDefense to Receive Exclusive License from Shine Holdings II-28
Emergent BioSolutions Signs Agreement to License VaxImmune II-29
Universal Detection Signs Distribution Agreement with ADVNT II-29
Universal Detection Secures Gulf Security Order for Detection
KitsII-29
Dycor Technologies Wins Rheinmetall Landsystems Contract II-29
AVI BioPharma Secures Bioterrorism Response Therapies Contracts II-30
Emergent BioSolutions Wins HHS Anthrax Biodefense Contract II-30
Nanotherapeutics Wins Anti-Bioterrorism Drug Contract from
NIAID/ BARDA II-30
SRI International Secures Contract for Anti-Biological Threat
Drugs from DTRA II-31
Universal Detection Completes Foot Locker Order for
Bioterrorism Detection Kits II-31
PharmAthene Wins HHS Biodefense Contract II-31
Ibis Biosciences Receives Four New Contracts from Government II-32
Universal Detection Receives Guaranteed Order from SSI II-32
Ichor Receives Navy Contract for Vaccine Development II-32
PharmAthene Receives Contract to Develop Anthrax Anti-Toxin II-33
General Dynamics Canada Secures Contract from Canadian Forces II-33
Universal Detection Commences R&D for Portable Anthrax Detector II-34
BioFactura Completes Initial Clinical Testing II-34

6. PRODUCT LAUNCHES II-35
Smiths Detection Introduces SmartBio' Biological Agents Detector II-35
Safe Life Launches Triosyn Disposable Respirators II-35
Icx Unveils Integrated System for CBR Threat Detection, SafeAir' II-35
Innovative Biosensors Unveils BioFlash Biological Detector II-36
Lawrence Laboratory Develops Biological, Chemical Agent
Detection Machine II-36

7. FOCUS ON SELECT PLAYERS II-37
Acambis Plc (UK) II-37
AVI BioPharma, Inc. (USA) II-37



Blücher Gmbh (Germany) II-37
Evogen, Inc. (USA) II-37
Human Genome Sciences Inc. (USA) II-38
ICX Technologies, Inc. (USA) II-38
ILC Dover LP (USA) II-38
Medarex, Inc. (USA) II-39
Northrop Grumman Corporation (USA) II-39
PharmAthene, Inc. (USA)II-39
Scott Health & Safety (USA) II-40
Smiths Detection (USA) II-40
The Baker Company (USA)II-40
Universal Detection Technology (USA) II-41

8. GLOBAL MARKET PERSPECTIVE II-42
Table 1: World Recent Past, Current & Future Analysis for
Bioterrorism Detection Equipment by Geographic Region - US,
Europe, Asia (Including Japan), and Middle East Markets
Independently Analyzed with Annual Revenues in US$ Million for
Years 2006 through 2015 (includes corresponding Graph/Chart) II-42

Table 2: World Historic Review for Bioterrorism Detection
Equipment by Geographic Region - US, Europe, Asia (Including
Japan), and Middle East Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2001 through 2015
(includes corresponding Graph/Chart) II-43

Table 3: World 10-Year Perspective for Bioterrorism Detection
Equipment Market by Geographic Region - Percentage Share
Breakdown of Dollar Revenue for US, Europe, Asia (Including
Japan), and Middle East Markets for Years 2006, 2009, and 2015
(includes corresponding Graph/Chart) II-43

III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
A Case of Undue Importance III-1
Market Drivers III-2
Market Dampers III-2
Investment Bottlenecks III-2
Legislative Bottlenecks III-2
Government Biodefense Funding III-3
The Federal Biological Weapons Prevention and Defense Funding III-3
Table 4: The US Federal Government Spending on Bioweapons
Prevention and Defense - Allocation of Funds in US$
Million by Department/Agency from FY2001 to FY2007
(includes corresponding Graph/Chart) III-4

Table 5: The US Federal Government Spending on Bioweapons



Prevention and Defense - Percentage Share Breakdown of
Funds Allocation by Department/Agency for FY2001 and
FY2007 (includes corresponding Graph/Chart) III-5

Table 6: The US Federal Funding for the Department of
Health and Human Services by its Constituent Agencies and
Offices in US$ Million from FY2001-FY2007 (Including
Requested Funding for the Year 2007) (includes
corresponding Graph/Chart)III-6
The RDT&E Biodefense Funding III-6
Table 7: Biodefense Funding for Research, Development,
Testing and Evaluation (RTD&E) by Agency/Department in US$
Million from FY2001 to FY2007 III-7
Biodefense Prevention Funding III-8
Table 8: Federal Biodefense Prevention Funding in US$
Million from FY2001 to FY2007 (includes corresponding
Graph/Chart) III-8
Recent Awards for Biodefense Preparedness III-8
Government Biodefense Initiatives III-9
Project BioShield III-9
Pandemic and All-Hazards Preparedness Act III-10
Public Health Security and Bioterrorism Preparedness and
Response Act III-10
Government Departments / Agencies III-10
The Department of Health and Human Services III-10
The National Institutes of Health III-11
The Centers for Disease Control and Prevention III-11
The CDC Classification III-11
The CDC Regulated Shipment Agents III-13
The Department of Defense III-14
B.Market Analytics III-15
Table 9: US Recent Past, Current & Future Analysis for
Bioterrorism Detection Equipment Market - Annual Revenue in
US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart) III-15

Table 10: US Historic Review for Bioterrorism Detection
Equipment Market - Annual Revenue in US$ Million for Years
2001 through 2005 (includes corresponding Graph/Chart) III-15

Table 11: US Recent Past, Current & Future Analysis for
Bioterrorism Vaccines Market - Annual Revenue in US$ Million
for Years 2006 through 2015 (includes corresponding
Graph/Chart) III-16

Table 12: US Historic Review for Bioterrorism Vaccines
Market - Annual Revenue in US$ Million for Years 2001
through 2005 (includes corresponding Graph/Chart) III-16

2. EUROPEIII-17



Market Analysis III-17
Table 13: European Recent Past, Current & Future Analysis
for Bioterrorism Detection Equipment Market - Annual Revenue
in US$ Million for Years 2006 through 2015 (includes

Table 14: European Historic Review for Bioterrorism
Detection Equipment Market - Annual Revenue in US$ Million
Graph/Chart) III-18

3. ASIA III-19
A.Market Analysis III-19
ASEAN and Canada Forge Ties to Combat Bioterrorism III-19
China Plans Counter-bioterrorism Security System III-19
B.Market Analytics III-20
Table 15: Asian Recent Past, Current & Future Analysis for
Bioterrorism Detection Equipment Market - Annual Revenue in
US$ Million for Years 2006 through 2015 (includes

Table 16: Asian Historic Review for Bioterrorism Detection
Equipment Market - Annual Revenue in US$ Million for Years
2001 through 2005 (includes corresponding Graph/Chart) III-20

4. THE MIDDLE EAST III-21
Market Analysis III-21
Table 17: The Middle East Recent Past, Current & Future
Analysis for Bioterrorism Detection Equipment Market -
Annual Revenue in US$ Million for Years 2006 through 2015
(includes corresponding Graph/Chart) III-21

Table 18: The Middle East Historic Review for Bioterrorism
Detection Equipment Market - Annual Revenue in US$ Million
Graph/Chart) III-22

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 66 (including Divisions/Subsidiaries - 67)



Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.

Bioterrorism

Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 3 950.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________



Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


Bioterrorism

More Related Content

Viewers also liked

Similar to Bioterrorism

More from ReportLinker.com

Recently uploaded

Bioterrorism